undamentalytics Newsletter

Springer Timothy A: insider trades

Director at 2 companies we cover. 29 open-market purchases and no sales not made under a pre-set plan, reported from May 19, 2017 to April 11, 2025.

Would copying Springer Timothy A’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 16 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on May 22, 2017 into $4,115 by November 2, 2026, −9.0% a year. The copy held shares only 33% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $17,323, +6.0% a year (the S&P 500 held throughout made $36,607, +14.8% a year). Beta against the index was 0.37. Twelve months after each report, the average purchase was −49.8% against the S&P 500 (median −59.8%), and 13% beat it. Measured from the trade date, the insider’s own timing, the average was −45.8%.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 20172019202120232025 $36.6k$17.3k$4.1k
Copying Springer Timothy AS&P 500, same days investedS&P 500, held throughout $10,000 copying Springer Timothy A’s open-market purchases from May 22, 2017, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−9.0%
S&P 500, same days invested
+6.0% (held throughout +14.8%)
Time in shares
33%
Sharpe ratio (S&P 500)
−0.02 (0.70)
Biggest drop (S&P 500)
−83% (−34%)
Market sensitivity (beta)
0.37
Purchases copied
16

Trade by trade

Springer Timothy A: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 16 −9.3% −14.0% 38% 3 — — Not enough years
Purchases, 6 months after the report 16 −32.8% −43.5% 19% 3 — — Not enough years
Purchases, 12 months after the report 16 −49.8% −59.8% 13% 3 — — Not enough years
Purchases, 12 months after the trade 16 −45.8% −63.3% 13% 3 — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Cartesian Therapeutics, Inc. RNAC —240May 19, 2017April 11, 2025
Tectonic Therapeutic, Inc. TECX —50September 26, 2024April 11, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
April 11, 2025April 9, 2025 TECX Purchase $2,299,015 +10.2%+34.4%+51.4%
April 11, 2025April 9, 2025 RNAC Purchase $1,522,330 −14.1%−82.6%−74.3%
April 9, 2025April 7, 2025 TECX Purchase $8,550,000 +19.2%+45.7%+63.8%
March 20, 2025March 18, 2025 RNAC Purchase $1,371,173 −45.5%−79.3%−74.0%
February 7, 2025February 5, 2025 TECX Purchase $39,999,977 −37.1%−52.4%−63.6%
January 15, 2025January 13, 2025 RNAC Purchase $366,353 −33.8%−77.7%−78.5%
December 23, 2024December 19, 2024 RNAC Purchase $965,005 −14.0%−80.7%−85.8%
November 18, 2024November 14, 2024 RNAC Purchase $7,372,444 +6.9%−71.7%−67.8%
October 24, 2024October 22, 2024 TECX Purchase $10,077,000 −37.9%−72.1%−70.3%
October 4, 2024October 2, 2024 RNAC Purchase $4,293,375 −28.5%−75.2%−63.9%
September 26, 2024September 26, 2024 TECX Purchase $1,440,829 +49.2%−67.2%−62.9%
August 14, 2024August 12, 2024 RNAC Purchase $101,964 +10.2%−42.0%−32.4%
March 28, 2024January 17, 2024 RNAC Purchase $11,412 not yetnot yetnot yet
March 20, 2024March 18, 2024 RNAC Purchase $11,426 not yetnot yetnot yet
March 18, 2024March 14, 2024 RNAC Purchase $667,246 not yetnot yetnot yet
December 17, 2021December 15, 2021 RNAC Purchase $631,458 not yetnot yetnot yet
December 13, 2021December 9, 2021 RNAC Purchase $11,687,820 not yetnot yetnot yet
May 26, 2021May 24, 2021 RNAC Purchase $7,061,476 not yetnot yetnot yet
May 25, 2021May 21, 2021 RNAC Purchase $8,847,398 not yetnot yetnot yet
October 23, 2020October 21, 2020 RNAC Purchase $9,550,699 not yetnot yetnot yet
October 20, 2020October 16, 2020 RNAC Purchase $4,331,554 not yetnot yetnot yet
October 14, 2020October 9, 2020 RNAC Purchase $553,406 not yetnot yetnot yet
October 8, 2020October 6, 2020 RNAC Purchase $5,443,206 not yetnot yetnot yet
August 16, 2019August 14, 2019 RNAC Purchase $17,400 not yetnot yetnot yet
March 29, 2019November 10, 2017 RNAC Purchase $6,142,910 not yetnot yetnot yet
November 16, 2017November 14, 2017 RNAC Purchase $533,933 −22.1%−50.8%−45.7%
November 13, 2017November 9, 2017 RNAC Purchase $490,372 −14.4%−45.7%−48.7%
June 28, 2017June 27, 2017 RNAC Purchase $5,999,989 −6.6%−48.3%−47.8%
May 19, 2017May 17, 2017 RNAC Purchase $225,568 +9.0%−31.3%−31.5%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Springer Timothy A traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.